Onderzoeker
Nathalie Van den Berghe
- Disciplines:Moleculaire en celbiologie
Affiliaties
- Trellis Onderzoeksgroep (Afdeling)
Lid
Vanaf1 mei 2022 → Heden - Therapeutische en Diagnostische Antilichamen (Afdeling)
Lid
Vanaf28 aug 2017 → 31 dec 2021
Projecten
1 - 1 of 1
- Verbeteren van de behandeling van patiënten met chronische inflammatoire aandoeningen door identificatie van predictieve biomerkers en geneesmiddelconcentratie opvolging van nieuwe biologische geneesmiddelenVanaf28 aug 2017 → 31 dec 2021Financiering: FWO Strategische Onderzoeksbeurs
Publicaties
1 - 10 van 12
- Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's disease(2023)
Auteurs: Nathalie Van den Berghe, Dahham Alsoud, Bram Verstockt, Séverine Vermeire, Paul Declerck, Debby Thomas
- Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model(2022)
Auteurs: Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Winnie Kerstens, Madina Rasulova, Sam Noppen, Rana Abdelnabi, Piet Maes, et al.
- The value of therapeutic drug monitoring to guide treatment optimisation of biologicals in patients with chronic inflammatory diseases: focus on vedolizumab and ustekinumab(2021)
Auteurs: Nathalie Van den Berghe, Séverine Vermeire, Debby Thomas
- Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations(2021)
Auteurs: Nathalie Van den Berghe, Bram Verstockt, João Guedelha Sabino, Marc Ferrante, Séverine Vermeire, Paul Declerck, Debby Thomas
Pagina's: 988 - 993 - Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis(2020)
Auteurs: Nathalie Van den Berghe, Rani Soenen, Maya Imbrechts
- Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrations(2020)
Auteurs: Nathalie Van den Berghe, Séverine Vermeire, Marc Ferrante, Debby Thomas
- Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis(2020)
Auteurs: Nathalie Van den Berghe, Rani Soenen, Ann Gils
Pagina's: 390 - 397 - Regulatory Role for NK Cells in a Mouse Model of Systemic Juvenile Idiopathic Arthritis(2019)
Auteurs: Jessica Vandenhaute, Bert Malengier-Devlies, Maya Imbrechts, Nathalie Van den Berghe, Kourosh Ahmadzadeh, Carine Wouters, Patrick Matthys
Pagina's: 3339 - 3348 - Achieving mucosal healing in inflammatory bowel diseases: which drug concentrations need to be targeted?(2019)
Auteurs: Nathalie Van den Berghe, Ann Gils
Pagina's: 945 - 954 - Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized Therapy(2019)
Auteurs: Rani Soenen, Nathalie Van den Berghe, Ann Gils
Pagina's: 2232 - 2235